Collaborations

Currently funded collaborations include:
1) NIH SBIR with Drs. Bill Christ, Stewart Campbell (Ancora) and Prof. John Barnwell (Centres for Disease Control) in pre-clinical trials of my malaria vaccine against anaemia endpoints.
2) NIH-funded with Prof. Peter Seeberger, Department of Chemistry Massachusetts Institute of Technology (now Federal Institute of Technology, Zurich).
3) Grand Challenges for Global Health Program - Boosting innate immunity to treat infectious diseases' with Profs. Findlay (UBC), Dougan (Sanger), Falkow (Oxford), Jacobs (Einstein), Sansonetti (Pasteur), and Farrer (Wellcome).
4) The Gates Foundation IPTi trial with Drs. I. Mueller (PNGIMR) and J. Beeson (WEHI).
5) NHMRC/EU FP6 (, 406705) AGEMAL trial in Mozambiquan infants with Prof. Pedro Alonso (Barcelona).
6) EU-funded with Dr. Clara Menendez (Barcelona) FACS profiling and microarray analysis in a case control study of malarial anaemia in Mozambique to define cellular phenotypes and transcriptional profiles.
7) NHMRC , 516745 with Prof. Frank Christiansen, Drs. Campbell Witt (UWA) and Ivo Mueller (PNGIMR) on immunogenetics and immunological phenotypes in severe malaria case-control and longitudinal cohort studies.
8) NHMRC Program Grant with Prof. Alan Cowman (WEHI), Prof. Terry Speed (WEHI), Prof. Geoff McFadden (Uni. Melb), Prof. Brendan Crabb (Burnet), Dr. James Beeson (WEHI). Diverse activities.
9) Various longitudinal observational and time-to-reinfection cohorts in Mugil, and Albimana PNG with Dr Ivo Mueller (PNGIMR) and various national and international collaborators eg. Dr Chris King (Case-Western) funded by various sources including Cellex Corp., US Department of Veteran Affairs, NIH (to Dr. Mueller).
10) Development of a live attenuated blood-stage vaccine for malaria, funded by Grand Challenges Exploration, with Prof. Alan Cowman.
11) Development of a synthetic carbohydrate anti-toxic vaccine against malaria, with Dr. Stew Campbell (Ancora), funded by Grand Challenges Explorations.